364071-16-9 (OT-R antagonist 2,OT-R antagonist 2)

OT-R antagonist 2;

OT-R antagonist 2;Oxytocin receptor antagonist 2;364071-17-0;LS-192629;CHEMBL5308462;G13507;LS-192629OT-R antagonist 1;2-Pyrrolidinecarboxamide, N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino)-1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-, (2S)-;364071-16-9;(2S,4E)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-methoxyimino-1-[4-(2-methylphenyl)benzoyl]pyrrolidine-2-carboxamide;MS-28720;SCHEMBL4943198;LS192629;LS 192629;LS-192629OT-R antagonist 1?;OT-R-antagonist-1;DA-66399;364076-99-3;Q27081746;CS-5584;OT-R antagonist 1;Oxytocin receptor antagonist 1;HY-15015A;AKOS030526795;GTPL2192;

IBXGJPAYWMFXSF-OLFRMSBUSA-N

InChI=1S/C28H29N3O4/c1-19-8-6-7-11-24(19)20-12-14-22(15-13-20)28(34)31-18-23(30-35-2)16-25(31)27(33)29-17-26(32)21-9-4-3-5-10-21/h3-15,25-26,32H,16-18H2,1-2H3,(H,29,33)/b30-23+/t25-,26+/m0/s1

O=C([C@H](C/1)N(C(C2=CC=C(C3=CC=CC=C3C)C=C2)=O)CC1=N\OC)NC[C@@H](O)C4=CC=CC=C4